NCT02028494View on ClinicalTrials.gov

Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer

NAUnknownINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
Breast Cancer
Interventions
DRUG

Capecitabine

Two dosages comparison

Trial Locations (1)

1120

RECRUITING

SLACOM, Buenos Aires

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

lead

Latin American & Caribbean Society of Medical Oncology

OTHER